Phase I trial evaluating the tolerability of low-dose vs high-dose sufentanil/triazolam vs sufentanil alone in patients undergoing office-based procedures
Phase of Trial: Phase I
Latest Information Update: 22 Jan 2009
At a glance
- Drugs Sufentanil/triazolam (Primary) ; Sufentanil
- Indications Anxiety disorders; Procedural pain
- Focus Adverse reactions
- 22 Jan 2009 New trial record.
- 12 Jan 2009 Results reported by AcelRx in a media release.